Prentað þann 23. des. 2024
105/2021
Reglugerð um (12.) breytingu á reglugerð nr. 233/2001, um ávana- og fíkniefni og önnur eftirlitsskyld efni.
1. gr.
Í stað heitisins "heilbrigðis- og tryggingamálaráðherra" í 2. mgr. 2. gr., 1. mgr. 6. gr., á tveimur stöðum í 1. mgr. 7. gr. og í 8. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.
2. gr.
Í stað orðsins "ráðherra" á tveimur stöðum í 2. mgr. 2. gr. og í 3. mgr. 7. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.
3. gr.
Í stað orðanna "ávísun lyfja og gerð lyfseðla og reglugerð um afgreiðslu lyfseðla, áritun og afhendingu lyfja" í 3. mgr. 3. gr. reglugerðarinnar kemur: lyfjaávísanir og afhendingu lyfja, með síðari breytingum.
4. gr.
Í stað orðsins "ávísa" í 1. mgr. 4. gr., í fyrirsögn IV. kafla, á þremur stöðum í 1., 2. og 4. mgr. 10. gr., og á tveimur stöðum í 1.-2. mgr. 11. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: afgreiða.
5. gr.
Eftirfarandi breytingar verða gerðar á 5. mgr. 5. gr. reglugerðarinnar:
- Í stað heitisins "heilbrigðis- og tryggingamálaráðuneytinu" kemur: Lyfjastofnun.
- Í stað orðsins "ráðuneytið" kemur: Lyfjastofnun.
6. gr.
Í stað heitisins "heilbrigðis- og tryggingamálaráðuneytið" í 2. mgr. 6. gr., 2. mgr. 7. gr., 8. gr. og 1. mgr. 9. gr. reglugerðarinnar kemur, í viðeigandi beygingarfalli: Lyfjastofnun.
7. gr.
Í stað orðsins "ráðuneytinu" í 1. mgr. 9. gr. reglugerðarinnar kemur: Lyfjastofnun.
8. gr.
Í stað orðsins "Lyfjum" í 1. mgr. 10. gr. reglugerðarinnar kemur: Lyf.
9. gr.
Í stað orðanna "sé ávísað" í 3. mgr. 10. gr. reglugerðarinnar kemur: megi afgreiða.
10. gr.
Í stað orðsins "ávísuðu" í 12. gr. reglugerðarinnar kemur: afgreiddu.
11. gr.
Eftirfarandi breytingar verða á eftirtöldum efnum í fylgiskjali I:
Efni | Annað nafn | IUPAC (Alþjóðasamtök um hreina og hagnýta efnafræði) | Alþjóðasamningar | B | Undanþágur og athugasemdir |
1,4-butanediol | BD | butane-1,4-diol | x | 5) | |
4-fluoroamphetamine | 4-FA Para-fluoroamphetamine PFA | 1-(4-fluorophenyl)propan-2-amine | P II | ||
4'-Fluoro-α-pyrrolidinopentiophenone | 4-fluoro-α-PVP, 4F-alfa-PVP | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone | x | ||
4-methylethcathinone | 4-MEC | 2-ethylamino-1-(4-methylphenyl)propan-1-one | P II | ||
5F-AKB-48 | 5F-APINACA | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazol-3- carboxamid | PII | ||
5F-MDMB-PINACA | 5F-ADB | N-(1-methoxycarbonyl-2,2-dimethylpropyl)-1-(5- fluoropentyl)-1H-indazol-3-carboxamid | P II | ||
AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentylindazole-3-carboxamide | PII | |||
Carfentanil | Carfentanyl | Methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate | N IV | ||
Ethylphenidate | ethyl 2-phenyl-2-piperidin-2-ylacetate | P II | |||
MDMB-CHMICA | (methyl-2-(1-(cyclohexylmethyl)-1H-indol-3-carboxamido)-3,3-dimethylbutanoat) | PII | |||
Pentedrone | 1-phenyl-2-(methylamino)pentan-1-one | P II |
12. gr.
Í stað orðanna "1. mgr. 7. gr. lyfjalaga, nr. 93/1994 með síðari breytingum," og "7. mgr. 7. gr. sömu laga" í 4. tölul. í kaflanum "Undanþágur og athugasemdir" í fylgiskjali I kemur á tveimur stöðum: lyfjalögum.
13. gr.
Við kaflann "Undanþágur og athugasemdir" í fylgiskjali I bætist við nýr töluliður, sem verður svohljóðandi:
5) Eftirfarandi er einnig undanþegið innflutnings- og útflutningsleyfi:
- Vörur sem heimilt er að markaðssetja hér á landi skv. annarri löggjöf en innihalda efnið í snefilmagni.
- Efnið sjálft ef tilætluð not þess eru til iðnaðarframleiðslu og lokaafurðin sem framleidd er hefur ekki eða er ekki talin hafa geðvirk áhrif og hráefnið getur ekki eða er ekki endurheimt frá lokaafurðinni.
14. gr.
Eftirfarandi efni bætast við lista í fylgiskjali I:
Efni | Annað heiti | IUPAC (Alþjóðasamtök um hreina og hagnýta efnafræði) og önnur fræðiheiti | Alþjóða samningar | B | Undanþágur/ athugasemdir |
1P-LSD | 1-propionyllysergid | N,N-diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide | x | ||
2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | 2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | x | |||
2-(ethylamino)propiophenone | 2-(ethylamino)-1-phenylpropan-1-one | x | |||
2,3-DMMC | 2,3-dimethylmethcathinone | x | |||
2,4-DMMC | 2,4-dimethylmethcathinone | x | |||
2,4-DMPPP | 1-(2,4-dimethylphenyl)-2-pyrrolidine-1-yl-propan-1-one | x | |||
2,5-dimethoxy-4-fluoroamphetamine | 1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine | x | |||
2,5-dimethoxy-4-nitroamphetamine | 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine | x | |||
25B-NBF | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25B-NBOH | 2-([2-(4-bromo-2,5-dimethoxyphenyl)ethylamino]methyl)phenol | x | |||
25C-NBF | 2-(4-chloro-2,5-dimethoxiphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25E-NBOH | 2-[([2-(4-ethyl-2,5-dimethoxiphenyl)ethyl]amino)methyl]phenol | x | |||
25E-NBOMe | 2-(4-ethyl-2,5-dimethoxiphenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
25G-NBOMe | 2-(2,5-dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
25I-NB34MD | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(3,4-methylenedioxyphenyl)methyl]ethanamine | x | |||
25I-NBF | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine | x | |||
25I-NBMD | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2,3-methylenedioxyphenyl)methyl]ethanamine | x | |||
25I-NBOH | 2-([2-(4-iodo-2,5-dimethoxyphenyl)ethylamino]methyl)phenol | x | |||
25N-NBOMe | 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine | x | |||
2C-B-FLY | 2-(8-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)ethanamine | x | |||
2C-F* | 2,5-dimethoxy-4-fluorophenethylamine | x | |||
2C-H | 2,5-dimethoxyphenethylamine | x | |||
2-Cl-4,5-MDMA | 2-chloro-4,5-methylenedioxymethamphetamine | x | |||
2-CMC | 2-Chloromethcathinone | 1-(2-chlorophenyl)-2-(methylamino)-1-propanone | x | ||
2-MEC | 2-methyl-N-ethylcathinone | x | |||
2-methylacetylfentanyl | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-methylphenyl)acetamide | x | |||
2-methylamphetamine | 2-MA | 1-(2-methylphenyl)propan-2-amine | x | ||
2-(methylamino)hexanophenone | 2-methylamino-1-phenylhexan-1-one | x | |||
2-methyl-AP-237 | 1-[4-(3-phenylprop-2-en-1-yl)-2-methylpiperazin-1-yl]butan-1-one | x | |||
3,4-DCEC | 3,4-dichloroethcathinone | x | |||
3,4-Dichloro-N,N-cyclohexylmethylmethcathinone | 2-(cyclohexyl(methyl)amino)-1-(3,4-dichlorophenyl)propan-1-one | x | |||
3,4-dichloromethylphenidate | methyl-2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate | x | |||
3,4-Dimethoxy-α-PHP | 1-(3,4-dimethoxyphenyl)-2-pyrrolidin-1-ylhexan-1-one | x | |||
3,4-DMA | 3,4-dimethoxyamphetamine | x | |||
3,4-methylenedioxy-U-47700 | N-[2-(dimethylamino)cyclohexyl]-N-methyl-2H-1,3-benzodioxol-5-carboxamide | x | |||
3-bromomethcathinone | 3-BMC | 1-(3-bromophenyl)-2-(methylamino)propan-1-one | x | ||
3-Desoxy-MDPV | 5-DMFPV | 5-dihydrobenzofuranpyrovalerone | x | ||
3-Fluorofentanyl | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | x | |||
3-fluoroethylamphetamine | 3-FEA | N-ethyl-1-(3-fluorophenyl)propan-2-amine | x | ||
3-fluorophenmetrazine | 3-FPM | 2-(3-fluorophenyl)-3-methylmorpholine | x | ||
3-hydroxyphenazepam | 7-bromo-3-hydroxy-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
3-hydroxyphencyclidine | 3-HO-PCP | 3-[1-(piperidin-1-yl)cyclohexyl]phenol | x | ||
3-chloroethcathinone | 3-CEC | 2-(ethylamino)-1-(3-chlorophenyl)propan-1-one | x | ||
3-methoxyeticyclidine | 3-MeO-PCE | N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine | x | ||
3-methylcrotonylfentanyl | 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | x | |||
3-methylflephedrone | 1-(3-fluorophenyl)-2-(methylamino)propan-1-one | x | |||
3-phenylpropanoylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-3-phenylpropanamide | x | |||
4,4'-dimethylaminorex | 4,4'-DMAR | 2-amino-4-methyl-5-(4-methylphenyl)-2-oxazoline | P II | ||
4-AcO-DMT | 4-acetoxy-N,N-dimethyltryptamine | x | |||
4-AcO-MET | 4-acetoxy-N-methyl-N-ethyltryptamine | x | |||
4-anilinopiperidine | 4-AP | N-phenyl-4-piperidinamine | x | ||
4-BMC | 4-bromomethcathinone | x | |||
4Br-α-PPP | 4-bromo-α-pyrrolidinopropiophenone | x | |||
4Br-α-PVP | 4-bromo-α-pyrrolidinovalerophenone | x | |||
4-CA | 4-chloroamphetamine | x | |||
4-CBC | 4-chloro-N-butylcathinone | x | |||
4-CEC | 4-chloroethcathinone | x | |||
4-CIC | 4-chloroisopropylcathinone | x | |||
4-CMA | 4-chloromethamphetamine | x | |||
4-EMC | 1-(4-ethylphenyl)-2-(methylamino)propan-1-one | x | |||
4-FEC | 4-fluoroethcathinone | x | |||
4-Fluoroethylamphetamine | 4-FEA | N-ethyl-4-fluoro-α-methyl-benzeneethanamine | x | ||
4-Fluoro-N-isopropylnorpentedrone | 1-(4-fluorophenyl)-2-(1-methylethylamino)pentan-1-one | x | |||
4-fluorobufedrone | 1-(4-fluorophenyl)-2-(methylamino)butan-1-one | x | |||
4-fluorobutyrfentanyl | 4F-BF | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-fluorophenyl)butanamide | x | ||
4-fluoroisobutyrfentanyl | 4F-Ibf, pFIBF | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-fluorophenyl)-2-methylpropanamide | N I | ||
4-fluoromethylphenidate | 4F-MPH | methyl-2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | x | ||
4F-MDMB-BINACA | methyl-2-[1-(4-fluorobutyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
4F-NEB* | 4-fluoro-N-ethylbuphedrone,2-(ethylamino)-1-(4-fluorophenyl)butan-1-one | x | |||
4F-NEP | 4-fluoro-N-ethylpentedrone | x | |||
4F-PBP | 4-fluoro-α-pyrrolidinobutyrophenone | x | |||
4F-α-PHiP | 4-fluoro-α-pyrrolidinoisohexanophenone | 4-methyl-1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
4F-α-PHP | 4-fluoro-α-pyrrolidinohexanophenone | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | x | ||
4-Hydroxymethcathinone | 1-(4-hydroxyphenyl)-2-(methylamino)propan-1-one | x | |||
4-chloro-isobutyrfentanyl | Para-chloroisobutyrfentanyl | N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide | x | ||
4-chloropentedrone | 4-chloro-α-methylaminovalerophenone | x | |||
4-MeOPBP* | 4'-methoxy-α-pyrrolidinobutiophenone | x | |||
4-MeO-PCP | 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine | x | |||
4-MeO-α-PVP | 4-methoxy-α-pyrrolidinovalerophenone | x | |||
4-methoxybutyrfentanyl | 4-MeO-BF | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(4-methoxyphenyl)butanamide | x | ||
4-methylmethylphenidate | methyl-2-(4-methylphenyl)-2-(piperidin-2-yl)acetate | x | |||
4-methyl-α-ethylaminopentiophenone | 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone | x | |||
4-methyl-α-PiHP | 4-methyl-α-pyrrolidinoisohexanophenone | 4-methyl-1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | x | ||
5Cl-AKB-48 | N-(adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5Cl-APINACA | N-(1-adamantyl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5Cl-AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazol-3-carboxamide | x | |||
5-DBFPV | 5-dihydrobenzofuranpyrovalerone | x | |||
5-EAPB | 5-(N-ethyl-2-aminopropyl)benzofuran | x | |||
5F-AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide | x | |||
5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
5F-AKB-57 | adamantyl-1-(5-fluoropentyl)-1H-indazol-3-carboxylate | x | |||
5F-AMB-PICA | N-(1-methoxycarbonyl-2-methylpropyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
5F-CUMYL-PeGACLONE | 2-(2-phenylpropan-2-yl)-5-(5-fluoropentyl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | x | |||
5F-EDMB-PINACA | ethyl-2-[1-(5-fluoropentyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
5F-MDMB-PICA | methyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoate | x | |||
5F-PB-22 | 8-quinolinyl-1-(5-fluoropentyl)-1H-indol-3-carboxylate | PII | |||
5-FUR-144 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | PII | ||
5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine | x | |||
5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine | x | |||
5-MeO-DET | N,N-diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine | x | |||
5-MeO-EIPT | 5-metoxy-N-ethyl-N-isopropyltryptamine | x | |||
5-MeO-MALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine | x | |||
5-MeO-NIPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine | x | |||
5-Metoksymetylon | bk-MMDMA | β-keto-5-metoxy-3,4-methylenedioxymethamphetamine | x | ||
6-allyl-6-norLSD | AL-LAD, 6-allylnorlysergide | 6-allyl-N,N-diethyl-9,10-didehydroergolin-8-carboxamide | x | ||
6-MAM | 6-monoacetylmorphine | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 6-acetate | x | ||
6-methoxy-MDA | 6-methoxy-3,4-methylenedioxyamphetamine | x | |||
AB-CHMINACA | N-(1-aminocarbonyl-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide | PII | |||
Acetylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | N I | |||
A-CHMINACA | N-(1-adamantyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamide | x | |||
Acrylfentanyl | ACRYLOYLFENTANYL | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide | N I | ||
ADB-CHMINACA | MAB-CHMINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide | P II | ||
ADB-FUBINACA | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazol-3-carboxamide | P II | |||
Adinazolam | 1-(6-phenyl-8-chloro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | x | 4) | ||
ALD-52 | 1-acetyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide | x | |||
AM-2201 chlorine analog | (1-(5-chloropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
AM-2201 N-(3-fluoropentyl) isomer | (1-(3-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | x | |||
AM-679 | (1-pentyl-1H-indol-3-yl)(2-iodophenyl)methanone | x | |||
AMB-CHMINACA | methyl-2-([1-(cyclohexylmethyl)-1H-indazol-3-carbonyl]amino)-3-methylbutanoate | x | |||
AMB-FUBINACA | MMB-FUBINACA, FUB-AMB | N-(1-methoxycarbonyl-2-methylpropyl)-1-(p-fluorobenzyl)-1H-indazol-3-carboxamide | PII | x | |
Apinaca | N-(1-adamantyl)-1-pentyl-1H-indazol-3-carboxamide | x | |||
Benzodioxole-fentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide | x | |||
Benzoylbenzylfentanyl | N-(1-benzylpiperid-4-yl)-N-phenylbenzamide | x | |||
Benzoylecgonin | (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid | x | |||
Benzoylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-benzamid | x | |||
Benzylfentanyl | N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide | x | |||
bk-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone | x | |||
bk-3,4-MDPA | Propylon | β-keto-3,4-methylenedioxypropylamphetamine | x | ||
bk-6-metoxy-MDMA | N-Methyl-bk-MMDA-2; | β-keto-6-metoxy-3,4-methylenedioxymethamphetamine | x | ||
bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-one | x | |||
bk-IVP | 1-(2,3-dihydro-1-inden-5-yl)-2-(ethylamino)pentan-1-one | x | |||
bk-MDEA | β-keto-methylenedioxy-N-ethylamphetamine | x | |||
bk-MDMA | β-keto-3,4-methylenedioxymethamphetamine | P II | |||
BMDB* | 2-benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one | x | |||
BMDP | 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one | x | |||
Bromadoline | 4-bromo-N-[2-(dimethylamino)cyclohexyl]benzamide | x | |||
Bromazolam | 8-bromo-6-phenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
Butyrfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide | N I | |||
C30-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine | x | |||
Chloro-isobutyrylfentanyl | N-(2-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide N-(3-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide N-(4-chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4- piperidyl]propanamide | x | |||
Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Cloniprazepam | 1-(cyclopropylmethyl)-5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-[1,4]- benzodiazepin-2-one | x | |||
CUMYL-4CN-BINACA | N-(1-methyl-1-phenylethyl)-1-(4-cyanobutyl)-1H-indazol-3-carboxamide | P II | |||
CUMYL-5F-P7AICA | N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-7-azaindol-3-carboxamid | x | |||
CUMYL-5F-PINACA | N-(2-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-carboxamide | x | |||
CUMYL-CHMGACLONE | 5-(cyclohexylmethyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | x | |||
CUMYL-PeGACLONE | 2-(2-phenylpropan-2-yl)-5-pentyl-2,5-dihydro-1H-pyrido[4,3- b]indol-1-one | x | |||
CUMYL-PICA | N-(2-phenylpropan-2-yl)-1-pentyl-1H-indol-3-carboxamide | x | |||
Cyclopentylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]cyclopentanecarboxamide | x | |||
Cyclopropylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide | N I | |||
Deschloroetizolam | 2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Deschloro-N-ethylnorketamine | O-PCE | 2-(ethylamino)-2-phenylcyclohexan-1-one | x | ||
Desoxy-D2PM | 2-(diphenylmethyl)pyrrolidine | x | |||
Despropionylfluorofentanyl | N-(2-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine N-(3-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine N-(4-Fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine | x | |||
Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one | x | |||
Dichloropane | RTI-111 | methyl-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-carboxylate | x | ||
Dimethocaine | [3-(diethylamino)-2,2-dimethylpropyl] 4-aminobenzoate | x | |||
Dipentylon | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | x | |||
Diphenidine | difenidin | 1-(1,2-diphenylethyl)piperidine | x | ||
DL-4662 | 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one | x | |||
DOPR | 2,5-dimethoxy-4-propylamphetamine | x | |||
DOT | 2,5-dimethoxy-4-methylthioamphetamine | x | |||
Eflea | N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-yl]-N-methylhydroxylamine | x | |||
Ephenidine | N-ethyl-1,2-diphenylethylamine | x | |||
Etaqualone | 3-(2-ethylphenyl)-2-methylquinazolin-4(3H)-one | x | |||
ETH-LAD | N,N,6-triethyl-9,10-didehydroergoline-8-carboxamide | x | |||
Ethylon | etylon, ethylone | 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-on | P II | ||
Flualprazolam | 6-(2-fluorophenyl)-8-chloro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
Flubromazepam | 7-bromo-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one | x | |||
Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Fluorobutyrylfentanyl | N-(2-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid N-(3-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid N-(4-fluorophenyl)-N-[(1-(2-phenylethyl)-4-piperidinyl)]butanamid | x | |||
Fluoro-isobutyrylfentanyl | N-(2-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid N-(3-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid | NI | |||
FUB-144 | (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | x | |||
Furanylethylfentanyl | N-[1-[2-(2-furanyl)ethyl]piperidin-4-yl]-N-phenyl-propanamide | x | |||
Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide | N I | |||
Gamma-Butyrolactone | GBL 4-butyrolactone | oxolan-2-one | x | 5) | |
Hexedrone | 2-methylamino-1-phenylhexan-1-one | x | |||
I-AMB | methyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]carboxamido)-3- methylbutanoate | x | |||
isopropylphenidate | Isopropyl-2-phenyl-2-(piperidin-2-yl)acetate | x | |||
Isopropyl-U-47700 | N-[2-(dimethylamino)cyclohexyl]-3,4-dichloro-N-(propan-2-yl)benzamide | x | |||
Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1- yl]ethan-1-amine | x | |||
JWH-308 | naphthalen-1-yl[5-(4-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]methanone | x | |||
JWH-309 | naphthalen-1-yl[5-(1-naphthalenyl)-1-pentyl-1H-pyrrol-3-yl]-methanone | x | |||
JWH-368 | naphthalen-1-yl(5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)methanone | x | |||
JWH-369 | [5-(2-chlorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | x | |||
LSZ | 8b-(2,4-dimethylazetidin-1-yl)carbonyl-9,10-didehydro-6-methylergoline | x | |||
MAM-2201 klór analog | (1-(5-chloropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | x | |||
MAM-2201 N-(3-fluoropentyl) analog | (1-(3-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | x | |||
MDAI | 5,6-methylenedioxy-2-aminoindane | (6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine) | x | ||
MDMB-4en-PINACA | methyl-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazol-3- carboxamido]butanoate | x | |||
MDMB-CHMINACA | methyl-2-([1-(cyclohexylmethyl)-1H-indazol-3-carbonyl]amino)-3,3-dimethylbutanoate | x | |||
MDPBP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | x | |||
MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | x | |||
Meclonazepam | 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-one | x | |||
MeO-diphenidine | 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine 1-(1-(3-methoxyphenyl)-2-phenylethyl)piperidine 1-(1-(4-methoxyphenyl)-2-phenylethyl)piperidine | x | |||
MeO-PCP | 1-(1-(2-methoxyphenyl)cyclohexyl)piperidine 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine 1-(1-(4-methoxyphenyl)cyclohexyl)piperidine | x | |||
MET | N-methyl-N-ethyltryptamine | x | |||
Methacrylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylmethacrylamide | x | |||
Methallylescaline | MAL | 2-[3,5-dimethoxy-4-(2-methylprop-2-enoxy)phenyl]ethanamine | x | ||
Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | x | |||
Methoxyacetylfentanyl | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | N I | |||
Methoxybutyrylfentanyl | N-(2-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid N-(3-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid | x | |||
Methiopropamine | MPA | N-methyl-1-(thiophen-2-yl)propan-2-amine | P II | ||
Metizolam | 4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
Methylclonazepam | 5-(2-chlorophenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
Methylnaphthidate | HDMP-28 | methyl-naphthalen-2-yl(piperidin-2-yl)acetate | x | ||
MIPT | N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | x | |||
MMB-022 | AMB-4en-PICA | methyl-3-methyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-carboxamido]butanoate | x | ||
MMB-CHMICA | AMB-CHMICA | methyl-2-[1-(cyclohexylmethyl)-1H-indol-3-carboxamido]-3- methylbutanoate | x | ||
MMB-FUBICA | AMB-FUBICA, FUB-AMB | methyl-2-[1-(4-fluorobenzyl)-1H-indol-3-carboxamido]-3-methylbutanoate | P II | ||
MMDA-2 | 6-metoxy-MDA | 6-methoxy-3,4-methylenedioxyamphetamine | x | ||
MOPPP* | 4'-methoxy-α-pyrrolidinoproiophenone | x | |||
MPHP* | 4-methylphenylpyrrolidinylhexanone | x | |||
MPhP-2201 | methyl-3-phenyl-2-[1-(5-fluoropentyl)-1H-indol-3-carboxamido]propanoate | x | |||
MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazin | N I | |||
N,N-dimethylpentylon | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone | x | |||
N-ethylhexedrone | NEH | 2-(ethylamino)-1-phenyl-hexan-1-one | x | ||
N-ethylisohexedrone | 2-(ethylamino)-4-methyl-1-phenyl-pentan-1-one | x | |||
N-ethylnorketamine | 2-(ethylamino)-2-(2-chlorophenyl)cyclohexan-1-one | x | |||
N-ethylnorpentylone | Efylon, ephylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone | P II | ||
N-ethyl-pentedron | NEP | 2-(ethylamino)-1-phenyl-pentan-1-one | x | ||
N-hydroxy-MDA | N-OH-MDA | N-hydroxy-α-methyl-1,3-benzodioxole-5-ethanamine | x | ||
Nifoxipam | 3-hydroxydesmethylflunitrazepam | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one | x | ||
Nitrazolam | 6-phenyl-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | x | |||
NM-2201 | naphthalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-carboxylate | x | |||
N-Methyl-2-AI | N-metyl-2AI, N-methyl-2-aminoindane | N-methyl-2,3-dihydro-1H-inden-2-amine | x | ||
Norfentanyl | N-phenyl-N-(piperidin-4-yl)propionamide | x | |||
Norfludiazepam | 5-(2-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | x | |||
N-Propylnorpentedrone | 1-phenyl-2-(propylamino)pentan-1-one | x | |||
Ocfentanil | ocfentanyl | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide | N I | ||
Orthoflurorofentanyl | 2-fluorofentanyl | N-[1-(2-phenylethyl)piperidin-4-yl]-N-(2-fluorophenyl)propanamide | N I | ||
Parafluorobutyrylfentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4- yl]butanamide | N I | |||
Pentylone | 1-(1,3-benzodioxol-5-yl)-2-(metylamino)pentan-1-one | x | |||
p-MePPP | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one | x | |||
Pregabalin | (3S)-3-(aminomethyl)-5-methylhexanoic acid | x | 4) | ||
Propylphenidate | propyl-2-phenyl-2-(piperidin-2-yl)acetate | x | |||
Proscaline | 4-Propoxy-3,5-DMPEA proscaline | 3,5-dimethoxy-4-propoxyphenethylamine | x | ||
PV9 | α-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | x | ||
Pyrazolam | 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
SDB-001 | N-(1-adamantyl)-1-pentyl-1H-indol-3-carboxamide | x | |||
SDB-006 | N-benzyl-1-pentyl-1H-indol-3-carboxamide | x | |||
Senecioylfentanyl | β'-methyl Crotonyl fentanyl, 3,3-Dimethylacrylfentanyl | 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | x | ||
SL-164 | 5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4(3H)-one | x | |||
STS-135 | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | x | |||
Tetrahydrofuranylfentanyl | tetrahydrofuranfentanyl, THF-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide | N I | ||
Tetramethylcyclopropylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyclopropane-1-carboxamide | x | |||
THJ-2201 | (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone | x | |||
TH-PHP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)hexan-1-one | x | |||
TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one | x | |||
Thiafentanil | methyl-4-[phenyl(methoxyacetyl)amino]-1-[2-(2-thienyl)ethyl]piperidin-4-carboxylate | x | |||
Tiletamine | 2-(ethylamino)-2-(thiophen-2-yl)cyclohexan-1-one | x | |||
U-47700 | 3,4-dichlor-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide | N I | |||
U-49900 | N-[2-(diethylamino)cyclohexyl]-3,4-dichloro-N-methylbenzamide | x | |||
UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | PII | |||
Valerylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]pentanamid | x | |||
W-15 | 4-chloro-N-(1-(2-phenylethyl)-piperidin-2-ylidene)benzenesulfonamide | x | |||
W-18 | 4-chloro-N-(1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene)benzenesulfonamide | x | |||
Zapizolam | 8-chloro-6-(2-chlorophenyl)-4H-pyrido[2,3-f][1,2,4]triazolo[4,3-a][1,4]diazepine | x | |||
α-diethylmethylaminopentiophenone | 1-fenyl-2-(1-metyletylamino)pentan-1-on | x | |||
α-Dimethylaminopentiophenone | x | ||||
α-EPP | α-ethylaminopentiophenone | x | |||
α-PCYP | 2-cyclohexyl-1-phenyl-2-(pyrrolidin-1-yl)ethan-1-one | x | |||
α-PEP | 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one | x | |||
α-PHP | 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one | x | |||
α-PHPP | α-pyrrolidinoheptophenone | x | |||
α-PNP | 1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one | x | |||
α-POP | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | x | |||
α-TMT | α-N,N-trimetyltryptamin | x | |||
β-hydroxy-3-methylfentanyl | N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide | N I + IV |
15. gr.
Við töflu í fylgiskjali II bætast eftirtalin efni:
Efni | Annað nafn | D I - II | Hámark án innflutningsleyfis |
3,4-MDP-2-P methyl glycidate | D I | ||
3,4-MDP-2-P methyl glycidic acid | D I | ||
alpha-Phenylacetoacetamide | APAA | D I |
16. gr. Gildistaka.
Reglugerð þessi, sem er sett með heimild í 53. gr. lyfjalaga nr. 100/2020 og 2. gr. laga um ávana- og fíkniefni nr. 65/1974 með síðari breytingum, öðlast þegar gildi.
Reglugerð þessi hefur verið tilkynnt í samræmi við ákvæði tilskipunar ESB 2015/1535 sem setur reglur um tilhögun upplýsingaskipta vegna tæknilegra reglna.
Heilbrigðisráðuneytinu, 20. janúar 2021.
F. h. r.
Ásta Valdimarsdóttir.
Hrönn Ottósdóttir.
Fyrirvari
Reglugerðir eru birtar í B-deild Stjórnartíðinda skv. 3. gr. laga um Stjórnartíðindi og Lögbirtingablað, nr. 15/2005, sbr. reglugerð um útgáfu Stjórnartíðinda nr. 958/2005.
Sé misræmi milli þess texta sem birtist hér í safninu og þess sem birtur er í útgáfu B-deildar Stjórnartíðinda skal sá síðarnefndi ráða.